2.90 +0.10 (3.52%)
DEPO
Stock Details
Last Trade:2.90 Change:+0.10 (3.52%) Prev Close:2.80 Open: 2.84 Days Range:2.84 – 2.93 52 Week Range: 1.66 - 6.40 Volume:235356 P/E: N/AEPS:-0.58
View AllRecent Alerts 02/10/10
Recent Alert on 02/01/10 at 9:02am
Depomed (DEPO) Receives U.S. FDA Notice of Allowance for Acuform Gastric Drug Delivery Tech
Depomed (DEPO) Receives U.S. FDA Notice of Allowance for Acuform Gastric Drug Delivery Tech
Depomed, Inc. (NASDAQ: DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U.S. patent application (No. 12/239,591) directed to pharmaceutical dosage forms that deliver the compound... Read More
Recent Alert on 02/01/10 at 9:02am
Depomed (DEPO) Receives U.S. FDA Notice of Allowance for Acuform Gastric Drug Delivery Tech
Depomed (DEPO) Receives U.S. FDA Notice of Allowance for Acuform Gastric Drug Delivery Tech
Recent Alert on 01/19/10 at 9:30am
Depomed (DEPO) Hot Flash Treatment Serada to Begin Additional Phase 3
Depomed (DEPO) Hot Flash Treatment Serada to Begin Additional Phase 3
Recent Alert on 01/19/10 at 9:30am
Depomed (DEPO) Hot Flash Treatment Serada to Begin Additional Phase 3
Depomed (DEPO) Hot Flash Treatment Serada to Begin Additional Phase 3
Recent Alert on 11/30/09 at 9:08am
Depomed (DEPO) Files Lawsuit Against Lupin For Orange Book GLUMETZA Patents
Depomed (DEPO) Files Lawsuit Against Lupin For Orange Book GLUMETZA Patents
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 11/16/09 at 10:33am
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza